We have previously reported on the activation of neuronal neurogranin (Nrgn) in T-cell lymphomas induced by SL3-3 integration in the Esam/Vsig2/Nrgn/Siae/Spa17 locus where the Nrgn expression level in lymphoid tumors corresponded to brain levels [60]. This evidence concerns the gene SPA17 and lymphoid neoplasm.